Article Versions Notes

Motais B, Charvátová S, Walek Z, Hrdinka M, Smolarczyk R, Cichoń T, Czapla J, Giebel S, Šimíček M, Jelínek T, et al. Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Cells. 2021; 10(5):967. https://doi.org/10.3390/cells10050967

Motais, Benjamin, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giebel, Michal Šimíček, Tomáš Jelínek, and et al. 2021. "Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment" Cells 10, no. 5: 967. https://doi.org/10.3390/cells10050967

Motais, B., Charvátová, S., Walek, Z., Hrdinka, M., Smolarczyk, R., Cichoń, T., Czapla, J., Giebel, S., Šimíček, M., Jelínek, T., Ševčíková, T., Sobotka, J., Kořístek, Z., Hájek, R., & Bagó, J. R. (2021). Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Cells, 10(5), 967. https://doi.org/10.3390/cells10050967